Irving, J., Matheson, E., Minto, L., Blair, H., Case, M., Halsey, C., . . . Eckert, C. (2014). Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood.
Dyfyniad Arddull ChicagoIrving, Julie, et al. "Ras Pathway Mutations Are Prevalent in Relapsed Childhood Acute Lymphoblastic Leukemia and Confer Sensitivity to MEK Inhibition." Blood 2014.
Dyfyniad MLAIrving, Julie, et al. "Ras Pathway Mutations Are Prevalent in Relapsed Childhood Acute Lymphoblastic Leukemia and Confer Sensitivity to MEK Inhibition." Blood 2014.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.